Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Inv. presentation
Employment agrmnt
Director departure
Appointed director

UNIGENE LABORATORIES INC (UGNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/02/2013 8-K Resignation/termination of a director
06/17/2013 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs: "Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of Victory Park Credit Opportunities Intermediate Fund, L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of Victory Park Credit Opportunities, L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of VPC Intermediate Fund II (Cayman), L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of VPC Fund II, L.P"
06/07/2013 8-K Quarterly results
05/29/2013 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
04/16/2013 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Concurrence from Grant Thornton LLP Regarding Change in Certifying Accountant"
04/12/2013 8-K Form 8-K - Current report
03/12/2013 8-K Quarterly results
Docs: "UNIGENE LABORATORIES, INC. BALANCE SHEETS DECEMBER 31, 2012 and 2011 2012 2011 ASSETS Current Assets: Cash and cash equivalents $ 3,813,492 $ 4,681,683 Accounts receivable 76,255 2,854,038 Accounts receivable - Tarsa -- 8,193 Inventory, net 898,042 1,283,550 Due from former China joint venture partner -- 600,000 Prepaid expenses and other current assets 848,573 862,761 Total Current Assets 5,636,362 10,290,225 Noncurrent inventory, net 1,063,633 1,946,647 Property, plant and equipment, net 2,651,819 2,977,058 Patents and other intangibles, net 1,920,574 2,020,458 Deferred financing costs, net -- 619,767 Other assets 40,513 341,014 Total Assets $ 11,312,901 $ 18,195,169 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable $ 731,359 $ 1,472,925 Accrued expenses 2,244,8..."
03/06/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Source: Unigene Laboratories, Inc."
12/21/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
12/21/2012 8-K Other Events
12/19/2012 8-K Other Events
11/27/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Source: Unigene Laboratories, Inc."
11/21/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Unigene Announces Third Quarter 2012 Corporate Update -Third Quarter Highlighted by Forbearance Agreement and First Amendment to Amended and Restated Financing Agreement with Victory Park Capital- -Management to host webcast and conference call today, November 20, 2012 at 11 a.m. ET- NOVEMBER 20, 2012 – BOONTON, N.J. -- Unigene Laboratories, Inc. today provided a corporate review on key development programs and strategic initiatives, including the Company’s ongoing progress following the debt financing and forbearance agreement with Victory Park Capital . THIRD QUARTER FORM 10-Q FILING"
10/16/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Source: Unigene Laboratories, Inc..."
10/03/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of 2012 Key Employee Performance and Incentive Agreement",
"Form of Stock Option Agreement",
"Employment Agreement between Unigene Laboratories, Inc. and Brian Zietsman",
"Stock Option Agreement between Unigene Laboratories, Inc. and Brian Zietsman",
"Employment Agreement between Unigene Laboratories, Inc. and Nozer Mehta"
09/26/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Second Amendment to Rights Agreement",
"Forbearance Agreement and First Amendment to Amended and Restated Financing Agreement, by and among the Company, the Lenders and Victory Park Management, LLC, as agent",
"Senior Secured Convertible Note, reissued by Company as of September 24, 2012 in favor of VPC Intermediate Fund II (Cayman), L.P",
"Senior Secured Convertible Note, reissued by the Company as of September 24, 2012 in favor of VPC Fund II, L.P",
"Senior Secured Convertible Note, reissued by the Company as of September 24, 2012 in favor of Victory Park Credit Opportunities Intermediate Fund, L.P",
"Senior Secured Convertible Note, reissued by the Company as of September 24, 2012 in favor of Victory Park Credit Opportunities, L.P",
"Senior Secured Convertible Note, issued by the Company as of September 21, 2012 in favor of VPC Fund II, L.P",
"Second Amended and Restated Registration Rights Agreement, by and among the Company and the Lenders",
"Indemnification Agreement between the Company and Richard N. Levy",
"Patent Security Agreement, by the Company in favor of Victory Park Management, LLC, as agent"
09/19/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Source: Unigene Laboratories, Inc."
09/07/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment No. 1 to the By-laws of Unigene Laboratories, Inc"
08/15/2012 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Source: Unigene Laboratories, Inc."
08/09/2012 8-K Quarterly results
Docs: "Tables to follow ### Unigene Laboratories, Inc. Condensed Balance Sheets June 30, 2012 and December 31, 2011"
07/26/2012 8-K Form 8-K - Current report
07/23/2012 8-K Regulation FD Disclosure
06/12/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement by and between Unigene Laboratories, Inc. and Ashleigh Palmer"
06/08/2012 8-K Regulation FD Disclosure
06/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Confidential Separation Agreement and General Release, between Unigene Laboratories, Inc. and William Steinhauer"
06/05/2012 8-K Investor presentation
Docs: "Presentation Materials"
06/04/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SOURCE: Unigene Laboratories, Inc."
05/22/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Investor Contact:"
04/09/2012 8-K Form 8-K - Current report
04/03/2012 8-K Form 8-K - Current report
04/02/2012 8-K Appointed a new director
Docs: "Investor Contact:"
03/22/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Investor Contact:"
03/16/2012 8-K Form 8-K - Current report
03/16/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Investor Contact:"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy